Epione® Post-Market Clinical Follow-up Study (SaFE)
Post-Market Clinical Follow-Up Study of a Robotic Device for Image Guided Percutaneous Needle Placement in the Abdomen
Sponsor: Quantum Surgical
A observational or N/A phase clinical study on Cancer Abdomen, this trial is completed. The trial is conducted by Quantum Surgical and has accumulated 7 data snapshots since 2022. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
7 versions recorded-
Feb 2026 — Present [monthly]
Completed
Status: Unknown → Completed
-
Oct 2025 — Feb 2026 [monthly]
Unknown
Status: Active Not Recruiting → Unknown
-
Sep 2024 — Oct 2025 [monthly]
Active Not Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting
-
Sep 2023 — Jul 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
▶ Show 2 earlier versions
-
Jan 2023 — Sep 2023 [monthly]
Recruiting
-
Sep 2022 — Jan 2023 [monthly]
Recruiting
First recorded
Apr 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Quantum Surgical
For direct contact, visit the study record on ClinicalTrials.gov .